Related Experiment Video
Updated: Oct 19, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Interferon beta-1b and childhood multiple sclerosis
A B Adams1, W R Tyor, K R Holden
1College of Medicine, Department of Neurology, Medical University of South Carolina, Charleston, USA.
Abstract:
The long-term treatment with interferon beta-1b of a 7-year-old male with relapsing-remitting multiple sclerosis is documented. Thirty-two months after initiating treatment, he demonstrates dramatic clinical improvement, without relapse, despite high titers of neutralizing antibodies to interferon beta-1b. It appears reasonable to attribute a role in his improvement to interferon beta-1b.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Multiple Sclerosis l: Introduction
Respiratory Syncytial Virus Disease
Cytomegalovirus Disease
Inhibitors Of Virion Release
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...